InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
PRJ
0.00%
0.0¢
PEPPER RESIDENTIAL SECURITIES TRUST NO.6 - Announcements
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
PRJ | Removal from Official List | 25/06/12 | ||
PRJ | PRJHA, HB and HC - Suspension from Official Quotation | PRICE SENSITIVE | 22/06/12 | |
PRJ | Call Notice | PRICE SENSITIVE | 13/12/11 | |
PRJ | Full Year Statutory Accounts | 01/09/10 | ||
PRJ | Special purpose financial report for the year ended 31/12/08 | 03/07/09 | ||
PRJ | Changes in Directors | 07/04/09 | ||
PRJRemoval from Official List | |||
25/06/12 | |||
PRJPRJHA, HB and HC - Suspension from Official Quotation | |||
22/06/12 | PRICE SENSITIVE | ||
PRJCall Notice | |||
13/12/11 | PRICE SENSITIVE | ||
PRJFull Year Statutory Accounts | |||
01/09/10 | |||
PRJSpecial purpose financial report for the year ended 31/12/08 | |||
03/07/09 | |||
PRJChanges in Directors | |||
07/04/09 | |||